Limitations of Cross-Talk Between Osteosarcoma and Bone Marrow-Derived Mesenchymal Stem Cells
Limitations of Cross-Talk Between Osteosarcoma and Bone Marrow-Derived Mesenchymal Stem Cells
Objectives: Metastasis is a multi-step process which leads the tumor cells to escape from primer tumor region due to their need to gain malignphenotypes. While the effect of bone marrow-derived mesenchymal stem cells upon metastasis is not certain, some studies point out bonemarrow-derived mesenchymal stem cells (BM-MSCs) to have this ability due to cell-cell interaction, released cytokines, and organization withthe extracellular matrix in the micro-environment. Cross-talk via soluble factors also shifts the metastatic character.Patients and Methods: In this study, the effects of mesenchymal stem cells on tumor behavior by creating different microenvironments in3-dimensional (3D) in vitro cancer model is analyzed. The BM-MSCs and osteosarcoma cells were co-cultured via hanging-drop modeled 3Dstructure in normoxic and hypoxic conditions, and the cross-talk was modeled to measure their chemoattractant effects. The invasion andmigration rates were measured with xCELLigence DP real-time cell analysis system. Mann Whitney U Test was used to compare independentsamples. All P-values
___
- 1. Siclari VA, Qin L. Targeting the osteosarcoma cancer stem cell. J
Orthop Surg Res BioMed 2010;5:78. [CrossRef]
- 2. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone
osteosarcoma in the pediatric age. State of the art. Cancer Treat Rev
2006;32:423–436. [CrossRef]
- 3. Tang N, Song WX, Luo J, Haydon RC, He TC. Osteosarcoma
development and stem cell differentiation. Clin Orthop Relat Res
2008;466:2114–2130. [CrossRef]
- 4. Caplan AI. The mesengenic process. Clin Plast Surg 1994;3:429–435.
- 5. Wagner W, Ho AD. Mesenchymal Stem Cell Preparations-Comparing
Apples and Oranges. Stem Cell Rev 2007;3:239–248. [CrossRef]
- 6. Robado de Lope L, Alcíbar OL, Amor López A, Hergueta-Redondo
M, Peinado H. Tumour-adipose tissue crosstalk: fuelling tumour
metastasis by extracellular vesicles. Philos Trans R Soc Lond B Biol Sci
2018;373:20160485. [CrossRef]
- 7. Peinado H, Zhang H, Matei I, et al. Pre-metastatic niches: organspecific homes for metastases. Nat Rev Cancer 2017;5:302–317.
[CrossRef]
- 8. Mishra PJ, Mishra PJ, Humeniuk R, et al. Carcinoma-associated
fibroblast-like differentiation of human mesenchymal stem cells.
Cancer Res 2008;68:4331–4339. [CrossRef]
- 9. Hass R, Otte A. Mesenchymal stem cells as all-round supporters in
a normal and neoplastic microenvironment. Cell Commun Signal
2012;10:26. [CrossRef]
- 10. Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D.
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.
Cancer Cell 2016;30:836–848. [CrossRef]
- 11. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors
in human bone marrow by a novel monoclonal antibody, STRO-1.
Blood 1991;78:55–62.
- 12. Ridge SM, Bhattacharyya D, Dervan E, et al. Secreted factors from
metastatic prostate cancer cells stimulate mesenchymal stem cell
transition to a pro-tumourigenic ‘activated’ state that enhances
prostate cancer cell migration. Int J Cancer 2018;142:2056–2067.
[CrossRef]
- 13. Jones E, McGonagle D. Human Bone Marrow Mesenchymal Stem
cells in vivo. Rheumatology (Oxford) 2008;47:126–131. [CrossRef]
- 14. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis
and function. Nat Rev Immunol 2002;2:569–579. [CrossRef]
- 15. Colombo M, Raposo G, Théry C. Biogenesis, Secretion, and
Intercellular Interactions of Exosomes and Other Extracellular
Vesicles. Annu Rev Cell Dev Biol 2014;30:255–289. [CrossRef]
- 16. Alfranca A, Martinez-Cruzado L, Tornin J, et al. Bone
microenvironment signals in osteosarcoma development. Cell Mol
Life Sci 2015;72:3097–3113. [CrossRef]
- 17. El-Badawy A, Ghoneim MA, Gabr MM, et al. Cancer cell-soluble
factors reprogram mesenchymal stromal cells to slow cycling,
chemoresistant cells with a more stem-like state. Stem Cell Res Ther
2017;8:254. [CrossRef]
- 18. Tu B, Du L, Fan QM, Tang Z, Tang TT. STAT3 activation by IL-6 from
mesenchymal stem cells promotes the proliferation and metastasis of
osteosarcoma. Cancer Lett 2012;325:80–88. [CrossRef]
- 19. Zhang P, Dong L, Yan K, et al. CXCR4-mediated osteosarcoma growth
and pulmonary metastasis is promoted by mesenchymal stem cells
through VEGF. Oncol Rep 2013;30:1753–1761. [CrossRef]
- 20. Bian ZY, Fan QM, Li G, Xu WT, Tang TT. Human mesenchymal stem
cells promote growth of osteosarcoma: Involvement of interleukin-6
in the interaction between human mesenchymal stem cells and Saos2. Cancer Sci 2010;101:2554–2560. [CrossRef]
- 21. Zhang P, Dong L, Long H, et al. Homologous mesenchymal stem cells
promote the emergence and growth of pulmonary metastases of
the rat osteosarcoma cell line UMR-106. Oncol Lett 2014;8:127–132.
[CrossRef]
- 22. Avnet S, Di Pompo G, Chano T, et al. Cancer-associated mesenchymal
stroma fosters the stemness of osteosarcoma cells in response
to intratumoral acidosis via NF-κB activation. Int J Cancer
2017;140:1331–1345. [CrossRef]
- 23. Mandel K, Yang Y, Schambach A, Glage S, Otte A, Hass R.
Mesenchymal Stem Cells Directly Interact with Breast Cancer Cells
and Promote Tumor Cell Growth In Vitro and In Vivo. Stem Cells Dev
2013;22:3114–3127. [CrossRef]
- 24. Zhang T, Lee YW, Rui YF, Cheng TY, Jiang XH, Li G. Bone marrowderived mesenchymal stem cells promote growth and angiogenesis of
breast and prostate tumors. Stem Cell Res Ther 2013;4:70. [CrossRef]
- 25. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous
expression of N-cadherin in breast cancer cells induces cell migration,
invasion, and metastasis. J Cell Biol 2000;148:779–790. [CrossRef]
- 26. Lammens T, Swerts K, Derycke L, et al. N-Cadherin in Neuroblastoma
Disease: Expression and Clinical Significance. PLoS One
2012;7:e31206. [CrossRef]
- 27. Zhuo H, Jiang K, Dong L, et al. Overexpression of N-cadherin is
correlated with metastasis and worse survival in colorectal cancer
patients. Chinese Sci Bull 2013;58:3529–3534. [CrossRef]
- 28. Rai H, Ahmed J. N-Cadherin: A Marker of Epithelial to Mesenchymal
Transition in Tumor Progression. Internet J Oncol 2014;10. Available
at: https://print.ispub.com/api/0/ispub-article/14796
- 29. Fang S, Yu L, Mei H, et al. Cisplatin promotes mesenchymallike characteristics in osteosarcoma through Snail. Oncol Lett
2016;12:5007–5014. [CrossRef]
- 30. Duval K, Grover H, Han L-H, et al. Modeling Physiological Events
in 2D vs 3D Cell Culture. Physiology (Bethesda) 2017;32:266–277.
[CrossRef]
- 31. Rahim S, Üren A. A real-time electrical impedance based technique
to measure invasion of endothelial cell monolayer by cancer cells. J
Vis Exp 2011;50. [CrossRef]
- 32. Liu Y, Feng Y, Liu H, Wu J, Tang Y, Wang Q. Real-time assessment of
platinum sensitivity of primary culture from a patient with ovarian
cancer with extensive metastasis and the platinum sensitivity
enhancing effect by metformin. Oncol Lett 2018;16:4253–4262.
[CrossRef]